Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation

Journal of General Virology

Volumn 82, Issue 9, 2001, Pages 2143-2150

  Nakayama, T ^a   Komase, K ^a   Uzuka, R ^a   Hoshi, A ^a   Okafuji, T ^a  

^a KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HYBRID PROTEIN; LEUCINE; LIVE VACCINE; MEASLES VACCINE; PHENYLALANINE; RECOMBINANT PROTEIN; RNA POLYMERASE; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BACTERIOPHAGE T7; CELL FUSION; CLONE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEASLES VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SYNCYTIUM; TEMPERATURE; VERO CELL; VIROGENESIS; VIRUS ATTENUATION; VIRUS PLAQUE; VIRUS PURIFICATION; VIRUS STRAIN;

EID: 0034852140     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-9-2143     Document Type: Article

References (39)

1. Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus
2. Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation
3. Virology of measles virus
4. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine
5. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion
6. Measles virus fusion protein is palmitoylated on transmembrane-intracytoplasmic cysteine residues which participate in cell fusion
7. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence
8. Paramyxovirus fusion protein: Characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation
9. Nucleotide sequence comparisons of the fusion protein gene from virulent and attenuated strains of rinderpest virus
10. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
11. Child mortality after high-titre measles vaccines: Prospective study in Senegal
12. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus
13. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion
14. Measles virus
15. Measles vaccines used in Japan
16. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion
17. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41
18. Paramyxovirus fusion: A hypothesis for changes
19. Development and characteristics of live AIK-C measles virus vaccine: A brief report
20. Molecular cloning and complete nucleotide sequence of genomic RNA of the AIK-C strain of attenuated measles virus
21. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability
22. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: A randomized controlled trial in Ghana
23. Pan American Health Organization Global measles efforts
24. Measles vaccine
25. Comparison of sequences of the H, F and N coding genes of measles virus strains
26. Molecular epidemiology of measles virus: Identification of pathways of transmission and implications for measles elimination
27. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain of AIK-L33) to chick embryo cells
28. Rescue of measles virus using a replication-deficient vaccinia-T7 vector
29. The attachment function of the Newcastle disease virus haemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation
30. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase
31. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins
32. Vaccinia virus recombinants expressing either the measles virus fusion or haemagglutinin glycoprotein protect dogs against canine distemper virus challenge
33. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months
34. Measles battle loses potent weapon
35. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months
36. Expanded Programme on Immunization: Safety of high titre measles vaccines
37. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein
38. Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion
39. Measles virus fusion: Role of the cysteine-rich region of the fusion glycoprotein